CAPRA-S

ورودی‌های بالینی بیمار

حداقل ۰.۱ — حداکثر ۲۰۰ • واحد: ng/mL

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
capra s
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • High risk≥ 6
  • Intermediate risk≥ 3
  • Low risk≥ 0
Direct Clinical Answer

The CAPRA-S calculates evaluating lower urinary tract symptoms, nephrolithiasis burden, and prostate cancer risk. Key inputs include psa. Scores guide initiating medical expulsive or alpha-blocker therapy, ordering renal imaging, or scheduling surgical intervention. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Cancer of the Prostate Risk Assessment post-surgical score.

Clinical Indication

The CAPRA-S is indicated for bedside clinical practice to support Cancer of the Prostate Risk Assessment post-surgical score.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with renal colic, hematuria, benign prostatic hyperplasia (BPH), or urogenital malignancies. Clinical application is indicated across Urology clinics, shock wave lithotripsy suites, and acute urologic surgical services.

Limitations & Contraindications

Serum PSA levels can be transiently elevated by acute prostatitis, urinary retention, or recent instrumentation.

Clinical Pearls & Action Plan

Obstructive urolithiasis complicated by upper urinary tract infection represents a surgical emergency requiring urgent decompression.

Formula & Variables:

PSA 0-3 + Gleason 0-3 + margin 0/2 + ECE 0/1 + SVI 0/2 + LNI 0/1; total 0-12.

Input Parameters

NameTypeRequiredDescription
psafloatYesPreoperative PSA(ng/mL)
gleasonstringYesle6: <=6, 3p4: 3+4, 4p3: 4+3, ge8: 8-10
surgical_marginstringYesSurgical margins: negative, positive
extracapsular_extensionstringYesExtracapsular extension: yes, no
seminal_vesicle_invasionstringYesSeminal vesicle invasion: yes, no
lymph_node_invasionstringYesLymph node invasion: yes, no

Score Interpretation & Guidance

RangeStageDescription
≥ 6High riskHigh risk of recurrence
≥ 3Intermediate riskIntermediate risk
≥ 0Low riskLow risk of recurrence

Evidence-Based References (EBM)

  • Cooperberg MR, Hilton JF, Carroll PR. The CAPRA-S score. Eur Urol. 2011;60(2):327-337.

Related calculators